Drug Interactions in Neurocritical Care

Brian Spoelhof, Salia Farrokh, Lucia Rivera Lara

Research output: Contribution to journalArticle

Abstract

Drug–drug interactions (DDIs) are common and avoidable complications that are associated with poor patient outcomes. Neurocritical care patients may be at particular risk for DDIs due to alterations in pharmacokinetic profiles and exposure to medications with a high DDI risk. This review describes the principles of DDI pharmacology, common and severe DDIs in Neurocritical care, and recommendations to minimize adverse outcomes. A review of published literature was performed using PubMed by searching for ‘Drug Interaction’ and several high DDI risk and common neurocritical care medications. Key medication classes included anticoagulants, antimicrobials, antiepileptics, antihypertensives, sedatives, and selective serotonin reuptake inhibitors. Additional literature was also reviewed to determine the risk in neurocritical care and potential therapeutic alternatives. Clinicians should be aware of interactions in this setting, the long-term complications, and therapeutic alternatives.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalNeurocritical Care
DOIs
StateAccepted/In press - Jan 4 2017

Fingerprint

Drug Interactions
Serotonin Uptake Inhibitors
Hypnotics and Sedatives
PubMed
Anticonvulsants
Anticoagulants
Antihypertensive Agents
Patient Care
Pharmacokinetics
Pharmacology
Therapeutics

Keywords

  • Adverse drug reactions
  • Antiepileptics
  • Calcium channel blockers
  • Drug interactions
  • Drug metabolism
  • Neurocritical care

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Clinical Neurology

Cite this

Drug Interactions in Neurocritical Care. / Spoelhof, Brian; Farrokh, Salia; Rivera Lara, Lucia.

In: Neurocritical Care, 04.01.2017, p. 1-10.

Research output: Contribution to journalArticle

Spoelhof, Brian ; Farrokh, Salia ; Rivera Lara, Lucia. / Drug Interactions in Neurocritical Care. In: Neurocritical Care. 2017 ; pp. 1-10.
@article{11745c99f6874d9aaf1b04ba19776678,
title = "Drug Interactions in Neurocritical Care",
abstract = "Drug–drug interactions (DDIs) are common and avoidable complications that are associated with poor patient outcomes. Neurocritical care patients may be at particular risk for DDIs due to alterations in pharmacokinetic profiles and exposure to medications with a high DDI risk. This review describes the principles of DDI pharmacology, common and severe DDIs in Neurocritical care, and recommendations to minimize adverse outcomes. A review of published literature was performed using PubMed by searching for ‘Drug Interaction’ and several high DDI risk and common neurocritical care medications. Key medication classes included anticoagulants, antimicrobials, antiepileptics, antihypertensives, sedatives, and selective serotonin reuptake inhibitors. Additional literature was also reviewed to determine the risk in neurocritical care and potential therapeutic alternatives. Clinicians should be aware of interactions in this setting, the long-term complications, and therapeutic alternatives.",
keywords = "Adverse drug reactions, Antiepileptics, Calcium channel blockers, Drug interactions, Drug metabolism, Neurocritical care",
author = "Brian Spoelhof and Salia Farrokh and {Rivera Lara}, Lucia",
year = "2017",
month = "1",
day = "4",
doi = "10.1007/s12028-016-0369-0",
language = "English (US)",
pages = "1--10",
journal = "Neurocritical Care",
issn = "1541-6933",
publisher = "Humana Press",

}

TY - JOUR

T1 - Drug Interactions in Neurocritical Care

AU - Spoelhof, Brian

AU - Farrokh, Salia

AU - Rivera Lara, Lucia

PY - 2017/1/4

Y1 - 2017/1/4

N2 - Drug–drug interactions (DDIs) are common and avoidable complications that are associated with poor patient outcomes. Neurocritical care patients may be at particular risk for DDIs due to alterations in pharmacokinetic profiles and exposure to medications with a high DDI risk. This review describes the principles of DDI pharmacology, common and severe DDIs in Neurocritical care, and recommendations to minimize adverse outcomes. A review of published literature was performed using PubMed by searching for ‘Drug Interaction’ and several high DDI risk and common neurocritical care medications. Key medication classes included anticoagulants, antimicrobials, antiepileptics, antihypertensives, sedatives, and selective serotonin reuptake inhibitors. Additional literature was also reviewed to determine the risk in neurocritical care and potential therapeutic alternatives. Clinicians should be aware of interactions in this setting, the long-term complications, and therapeutic alternatives.

AB - Drug–drug interactions (DDIs) are common and avoidable complications that are associated with poor patient outcomes. Neurocritical care patients may be at particular risk for DDIs due to alterations in pharmacokinetic profiles and exposure to medications with a high DDI risk. This review describes the principles of DDI pharmacology, common and severe DDIs in Neurocritical care, and recommendations to minimize adverse outcomes. A review of published literature was performed using PubMed by searching for ‘Drug Interaction’ and several high DDI risk and common neurocritical care medications. Key medication classes included anticoagulants, antimicrobials, antiepileptics, antihypertensives, sedatives, and selective serotonin reuptake inhibitors. Additional literature was also reviewed to determine the risk in neurocritical care and potential therapeutic alternatives. Clinicians should be aware of interactions in this setting, the long-term complications, and therapeutic alternatives.

KW - Adverse drug reactions

KW - Antiepileptics

KW - Calcium channel blockers

KW - Drug interactions

KW - Drug metabolism

KW - Neurocritical care

UR - http://www.scopus.com/inward/record.url?scp=85008158224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008158224&partnerID=8YFLogxK

U2 - 10.1007/s12028-016-0369-0

DO - 10.1007/s12028-016-0369-0

M3 - Article

C2 - 28054285

AN - SCOPUS:85008158224

SP - 1

EP - 10

JO - Neurocritical Care

JF - Neurocritical Care

SN - 1541-6933

ER -